Effectiveness of the vitamin drug Doctovit for correction of clinical symptomatology and restoration of life quality in complex therapy of chronic erosive H. pylori-associated gastritis
PDF (Українська)

Keywords

chronic erosive gastritis, H. pylori, vitamin drug, life quality, treatment

How to Cite

Gubergrits, N., Babinets, L., & Halabitska, I. (2019). Effectiveness of the vitamin drug Doctovit for correction of clinical symptomatology and restoration of life quality in complex therapy of chronic erosive H. pylori-associated gastritis. Herald of Pancreatic Club, 44(3), 62-69. https://doi.org/10.33149/vkp.2019.03.07

Abstract views: 8
PDF Downloads: 12

Abstract

Inclusion of the vitamin drug Doctovitin the complex treatment of patients with chronic erosive gastritis contributed to a statistically significant regression of clinical symptoms (p<0.05). This led to significant improvement of physical and psychological parameters of life quality: according to the SF-36 questionnaire scale — at the average of 4.9%, GSRS questionnairescale — by 17.2% (p<0.05), which proved the effectiveness and reasonability of using the vitamin drug in complex treatment and rehabilitation of patients with chronic erosive gastritis. It is expedient to prescribe 2 tablets of the vitamin complex Doctovit per day after eating during 2 months for the correction of polynutrient disorders in complex treatment of chronic erosive gastritis.

https://doi.org/10.33149/vkp.2019.03.07
PDF (Українська)

References

1. Губергриц Н. Б., Василенко И. В., Фоменко П. Г., Голубова О. А., Станиславская Э. Н. Доктовит: эффективность на уровне гистологии. Сучасна гастроентерологія. 2014. № 1 (75). С. 1–4.
2. Губергриц Н.Б., Налетов С.В., Фоменко П.Г. И сноварепаранты.Сучасна гастроентерологія. 2013. № 1 (69). С. 143–151.
3. Ивашкин В.Т., Шептулин А.А., Лапина Т.Л. Хронический гастрит, вызванный инфекцией Helicobacterpylori: диагностика, клиническо езначение, прогноз. Пособие для врачей. 2009. С. 22.
4. Ливзан М.А., Мозговой С.И., Кононов А.В. Гастрит после эрадикации Helicobacterpylori — простые следы или серьезные последствия? Лечащий врач. 2011. № 7. С. 7–9.
5. Bagchi D., McGinn T. R., Ye X.Mechanism of gastro protection by bismuth subsalicylateagainst chemical lyinducedoxidativ estressin cultured human gastricmucosal cells. Dig Dis Sci. 1999. Vol. 44. P. 2419–2428.
6. Forman D., Burley V. J. Gastriccancer: globalpatternofthediseaseandanoverviewofenvironmentalriskfactors. Best Pract Res Clin Gastroenterol. 2006. Vol. 20. P. 633–649.
7. Kelley J. R., Duggan J. M. Gastriccancerepidemiologyandriskfactors. J ClinEpidemiol. 2003. Vol. 56, No 1. P. 1–9.
8. Malfertheiner Р., Megraud F., O’Morain С.А.Management of Helicobacterpylori infection—the Maastricht IV/ Florence Consensus Report. Gut. 2012.Vol. 61, No 5. P. 646–664.